Excited to share insights from our work on MUC5AC in pancreatic ductal adenocarcinoma! Check out my talk for key findings and implications. #CancerResearch #PancreaticCancer vumedi.com/video/ascor-gi…

Gearing up for a strong #ASCO25—10 acceptances, including 3 posters spanning pancreatic, liver & biliary cancers. Highlighting novel cfDNA methylation, simple IHC, and retrospective analyses. Excited to showcase my work! Ohio State Medical Oncology

Hot off the press 🔥📰🔥 Delighted to share our latest publication: we demonstrate that serum MUC5AC has potential as a reliable biomarker 🧬 for predicting treatment-related outcomes in patients with resected pancreatic cancer. Ohio State Medical Oncology frontiersin.org/journals/oncol…

🚨 Our New Review Just Out! 🧬 We explore a decade of progress in blood-based biomarkers for pancreatic cancer — from cfDNA to CTCs, RNA, and protein signatures. 🔍 What’s next for early detection and personalized therapy? 📖 Read here: frontiersin.org/articles/10.33… Ohio State Medical Oncology

Are we overtreating locally advanced PDAC? PRODIGE 29 (UCGI 26): FOLFIRINOX showed a 2-month PFS benefit over gemcitabine, but no OS difference. Similar surgical conversion rates. Notably, most patients did not receive gem/Abraxane after progression. ascopubs.org/doi/10.1200/JC…

Excited to present our poster at #ASCO25! Showcasing the potential of cell-free DNA methylation sequencing in #PDA #PancreaticCancer. Unlocking the biology behind treatment response — #BiologyIsKing Let’s decode the epigenome! 🧬🧫🧠📊

The Potential of Cell-Free DNA Methylation Sequencing in Pancreatic Ductal Adenocarcinoma - Ashish Manne oncodaily.com/blog/cell-free… #Adenocarcinoma #ASCO25 #Cancer #MedEd #MedX #CellFreeDNAMethylationSequencing #PancreaticDuctalAdenocarcinoma #OncoDaily #Oncology

🎙️ Honored to present our research on pancreatic cancer at #ASCO25! Our work highlights emerging strategies to better predict outcomes and personalize treatment for patients with this challenging disease. #PancreaticCancer #PrecisionOncology #ASCO2025 Ohio State Medical Oncology

Congrats to our promoted faculty to Associate and Full Professors of the Ohio State Medical Oncology !! Your commitment, dedication and contributions are exceptional. The Ohio State University College of Medicine The James

🔍✨ Join us to explore groundbreaking research and key clinical trial updates from #ASCO25! 🧬💊 #Oncology #CancerResearch #ASCO2025

Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6dk

Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6qH